Barriers and Facilitators to HPV Vaccination: Perspectives from Malawian Women

Barriers and Facilitators to HPV Vaccination: Perspectives from Malawian Women
复制标题

DOI:
10.1080/03630242.2013.809046
复制
发表时间:
2013-08-01
期刊:
影响因子:
1.6
通讯作者:
Rameshbabu, Anjali
Rameshbabu, Anjali
中科院分区:
医学4区
文献类型:
--
作者:
Ports, Katie A.;Reddy, Diane M.;Rameshbabu, Anjali

文献摘要

被引文献

相似文献

这项研究的目的是阐明撒哈拉以南非洲国家马拉维接种人乳头瘤病毒 (HPV) 疫苗的潜在障碍和促进因素。在马拉维,每年每 10 万名女性中约有 31 人患宫颈癌,其中 80% 死于这种恶性肿瘤。 HPV 疫苗接种可能为马拉维预防宫颈癌提供可行的策略。然而,在接种疫苗之前,必须考虑个人及其社区对宫颈癌和 HPV 疫苗接种接受程度的重要问题和担忧。对来自 Chiradzulu 区 30 名 18-49 岁的马拉维母亲进行了定性访谈。深入探讨了妇女对 HPV、宫颈癌和疫苗接种的知识和信念及其社会生态背景。专题分析显示,尽管女性的知识有限,但宫颈癌仍被认为是一种严重的疾病。参与者认为,作为女性,她们对孩子的健康负责。妇女们一致表示,她们会给孩子接种 HPV 疫苗,尤其是在健康专业人士建议的情况下。马拉维的医疗保健基础设施可能会给 HPV 疫苗计划带来挑战;然而,参与者通常不会报告这是疫苗接种的障碍。这些数据揭示了可能影响马拉维 HPV 疫苗接种接受度和接种率的因素。
The aim of this research was to elucidate potential barriers and facilitators to human papillomavirus (HPV) vaccination in Malawi, a sub-Saharan country. In Malawi, approximately 31 out of every 100,000 women develop cervical cancer annually, and 80% of those affected die from this malignancy. HPV vaccination may provide a feasible strategy for cervical cancer prevention in Malawi. However, important questions and concerns regarding cervical cancer and HPV vaccination acceptance among individuals and their communities must be considered prior to vaccine delivery. Qualitative interviews were conducted with 30 Malawian mothers aged 18-49 years from Chiradzulu District. Women's knowledge and beliefs about HPV, cervical cancer, and vaccination, and their social-ecological contexts were explored in-depth. Thematic analyses revealed that despite women's limited knowledge, cervical cancer was perceived to be a serious disease. Participants believed that as women, they were responsible for their children's health. Women unanimously reported that they would vaccinate their children against HPV, especially if a health professional recommended it. Malawi's health care infrastructure could present challenges to HPV vaccine programs; however, participants did not typically report this to be a barrier to vaccination. These data shed light on factors that may influence HPV vaccination acceptance and uptake in Malawi.